Recent Authors

Linda Narhi

Proces, Protein Structure And Function, Protein-Based Therapeutics

[VIDEO] Linda Narhi: Innovation in the Process Development Organization at Amgen

The scientific executive director and head of technology development in PD introduced the many roles for scientists in this area of biotech.

Image: 09 july 2015 By Abby Tabor | Science Writer at NASA's Ames Research Center

When Dr. Linda Narhi first started at Amgen, "everything was R&D, because we didn’t even know if you could make a protein and use it as a drug.” As such products became a reality, process development became increasingly important. In this talk, Dr. Narhi reveals the roles and responsibilities of scientists working in PD, and the broader scientific vision it can bring.

When Dr. Linda Narhi first started at Amgen, the only protein that had been used as a pharmaceutical was insulin, which was a special case. “Back then, everything was R&D,” she says, “because we didn’t even know if you could make a protein and use it as a drug.” Indeed, you could, and as such products became a reality, process development became increasingly important. “Even though that’s the later half of making drugs, there’s still a lot of research there,” she explained in a talk on June 24^th. Dr. Narhi revealed to members of AIMS the roles and responsibilities of scientists working in PD, and the broader scientific vision it can bring you. Learn more about this career in industry in the video below.

Join us again Thursday, July 23^rd, for the next AIMS event. Details coming soon!

Biotech Industry Pharmaceuticals Academia Post-Doc Women In Science Aims Association Of Industry-Minded Stanford Professionals Linda Narhi Amgen Process Development Pd

Amir Marcovitz

Christophe Pichavant

Linda Narhi